Skip to content
Independent analysis of NHS open data
PharmaInsight

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide

Infections Antiviral drugs BNF 0503010BA
Data updated January 2026 Download CSV
3items

Dispensed in January 2026

3items

Rolling 12 months

£88

Net ingredient cost · January 2026

Figure 1. Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide: national items dispensed by month

0 1.5 3 Jan 2026 3 Jan 2026: 3

Source: NHSBSA Prescription Cost Analysis, to January 2026

Download CSV
Embed this chart

Free to reuse with the credit line above.

At a glance

  • Therapeutic class Antiviral drugs
  • Presentations 1 shown
  • Average cost / item £29.32
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, January 2026

The individual products dispensed under Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide this month.

Presentations of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide, January 2026
Presentation BNF code Items Net ingredient cost
Genvoya 150mg/150mg/200mg/10mg tablets 0503010BABBABAB 3 £88

Source: NHSBSA Prescription Cost Analysis · to January 2026 OGL v3.0

Where Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide is dispensed

The regions and dispensing practices with the highest Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide with

Other medicines in the same BNF section, by prescribing volume.

Download this data

The monthly series for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.